Needle and syringe programmes Implementing NICE guidance 2009 NICE public health guidance 18.

Slides:



Advertisements
Similar presentations
NICE Guidance on Needle and Syringe Programmes: Providing Injecting Equipment to People who Inject Drugs. Professor Mike Kelly, PhD, FFPH. Director, The.
Advertisements

Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
Needle and syringe programmes Working with Local Authorities:- A strategic and community development approach to planning applications.
Needle exchange: an NTA perspective 1 July 2009 Hugo Luck.
Graham Parsons. Pharmacist with Special Interest (PhwSI) NHS Plymouth.
Pharmacy: looking to the future Kevin Ratcliffe Consultant Pharmacist.
NEX in treatment services 8 August The guidance Ensure services offering opioid substitution therapy also make needle and syringes available to.
NSP PROVISION WITHIN SPECIALIST DRUG SERVICES. What is it? Integral part of Harm Reduction in nx provision Integral part of Harm Reduction in nx provision.
Delivering effective needle and syringe programmes: Implementing NICE guidance Working with Local Authorities: Planning Applications for Needle Exchanges.
Implementing NICE guidance
Maternal and child nutrition
Implementing NICE guidance
Attention deficit hyperactivity disorder Implementing NICE guidance 2008 NICE clinical guideline 72.
Tuberculosis (TB): clinical diagnosis and management of tuberculosis and measures for its prevention and control March 2006.
Depression in adults with a chronic physical health problem
Maternal and child nutrition
Quality improvement guide: prevention and control of healthcare-associated infections Learning and development resource for board members 2012 NICE public.
Implementing NICE guidance
Service user experience in adult mental health
Pregnancy and complex social factors
Implementing NICE guidance
Diabetic Foot Problems
For primary and secondary care settings
Metastatic spinal cord compression
Familial hypercholesterolaemia
Routine postnatal care of women and their babies
Type 2 diabetes Implementing NICE guidance 2009 NICE clinical guideline 87.
Community engagement Implementing NICE guidance 2008 NICE public health guidance 9.
and alcohol dependence
Skin cancer prevention: information, resources and environmental changes Implementing NICE guidance 2011 NICE public health guidance 32.
Responses to infectious diseases among people who inject drugs: Policies and measures taken in Europe Dagmar Hedrich, EMCDDA Project Imp.Ac:T - Improving.
Children and young people, injecting and HIV Under-18 and overlooked Young People and Injecting Drug Use: Overcoming barriers to HIV Prevention and Harmonizing.
MSH M SH Multi-Agency Support Hub. Background and context Ensuring children and families receive help at the most appropriate level of need The Process:
Mental Health, Drugs and Regions Division: Local Government Drug Issues Forum 11 August 2011.
MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.
Updating the NICE NSP Guidance Chris Carmona, Public Health Analyst Centre for Public Health.
Low back pain Implementing NICE guidance 2009 NICE clinical guideline 88.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
HIV and drug prevention in Estonia Harm reduction services
NACO and NACP. Response of Govt to HIV National AIDS Control Programme (NACP) under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999) NACP.
Implementing NICE guidance
Harm Reduction.
Early Help for Shropshire Children & Families Children’s Trust Area Forum.
The Policy Company Limited © Control of Infection.
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
Reaching out to drug users and communities “ ” WDP Preventing HIV Yasmin Batliwala.
NEEDLE AND SYRINGE PROGRAMMES IN THE UK Jamie Bridge, NNEF Chair
Targeted Interventions for IDUs – an overview. Targeted Intervention for IDUs - an Overview 2 Background  In Asia, 4.7 million people were infected with.
Lydia H. Guterman Consultant, Open Society Institute September 25, 2008 Sofia, Bulgaria Many thanks to the Harm Reduction Coalition for partial content.
MRCPsych addiction psychiatry seminar series Policy, guidance, service structures and legal framework of addiction treatment Epidemiology of addictive.
1 Needle Exchange Provision in Scotland Selected results from the National Needle Exchange Survey Dawn Griesbach Griesbach & Associates 28 February 2007.
Alcohol and Other Drugs (AOD) Stream Integrated service Located in regions across Tasmania.
Drug Misuse Monitoring Identifying Trends Predicting Future Demands Responding to Public Health Needs J McVeigh, MA Bellis & R Thomson.
Substance Misuse Treatment Framework – Needle Exchange Implications for planning and practice Carry Burton North Wales Needle Syringe Programme & Harm.
Developing a specialist community based service for adolescent drug users Jack Leach Consultant in substance misuse Young persons drug project, Bolton.
1 NTA More treatment, better treatment, fairer treatment National injecting conference Annette Dale-Perera Director of Quality.
WORKSHOP OBJECTIVES  To describe a research study designed to promote the involvement of older people and carers in strategic planning processes  To.
5-19 Children’s Public Health Service. Who are Provide? We provide a broad range of community services across Essex, Cambridgeshire and Peterborough,
Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.
Young Person’s substance misuse service in Hampshire Julie Poling – Team Leader.
Promoting physical activity for children and young people Schools and colleges Implementing NICE guidance 2009 NICE public health guidance 17.
Alcohol dependence and harmful alcohol use NICE quality standard August 2011.
Pharmacy White Paper Building on Strengths Delivering the Future Overview.
A DAY IN THE LIFE OF BOOTS QUEEN STREET STATION Lynda Allan Store Manager.
The Government’s Assistive Technology & Telecare Initiative Denise Gillie Department of Health.
The recovery agenda – a pharmacy perspective
Enhanced Pharmacy Provision in Edinburgh:
Addressing Drug Use Together Through a Health Based Approach:
Presentation transcript:

Needle and syringe programmes Implementing NICE guidance 2009 NICE public health guidance 18

What this presentation covers Background Scope Recommendations Discussion Find out more

Background 115, ,000 injecting drug users (IDUs) in England 23% of IDUs report recently sharing needles Over 40% of IDUs are Hepatitis C positive IDUs are ten times more likely to die prematurely than the rest of the population In 2006, over 1400 deaths were linked to controlled drugs

Scope The optimal provision of needle exchange and syringe programmes (NSPs) for people who inject illicit substances and non-prescribed anabolic steroids Majority of NSPs are run by pharmacies and drug services Some NSPs offer other services such as help to stop taking drugs This guidance refers to people of 18 years and older

Planning, needs assessment and community engagement LSPs, PCTs and D(A)ATS should collect and analyse local data on: problems/harms linked to injecting drug use e.g. infections number and characteristics of people who inject number of IDUs in regular contact an NSP number who have sterile injecting equipment available

LSPs, PCTs and D(A)ATS should Use data gathered to ensure services meet local need Consult people who inject drugs when planning NSPs Consult local communities Use the information collated to ensure NSP services meet local need During consultations with local communities: - promote the benefits of the service - actively involve communities Planning, needs assessment and community engagement

LSPs, PCTs and D(A)ATS should commission generic and targeted services to: increase the number of people who have more than one sterile syringe and needle available per injection reach more people from specific groups who inject offer advice, information and referral to harm reduction services Meeting need

LSPs, PCTs and D(A)ATS should Develop needle and syringe disposal plans Encourage needle and syringe identification schemes Commission integrated care for people who inject drugs Audit and monitor services Meeting need

LSPs, PCTs and D(A)ATS should - use pharmacies, specialist NSPs and other settings to provide a balanced mix of services: Level one - injecting equipment (loose or in packs) with written information on harm reduction Level two - bespoke equipment plus harm reduction and health promotion advice Level three - bespoke equipment, harm reduction advice plus specialist services Types of service

LSPs, PCTs and D(A)ATS should Ensure injecting equipment is available for a significant time during any 24-hour period Consider using community pharmacies that operate extended opening hours Ensure opioid substitution services also offer needles and syringes Types of service

Equipment and advice Needle and syringe programme providers should provide people who inject drugs with needles, syringes and other injecting equipment - at quantity based on need, not subject to arbitrary limit - where possible, in a range of sizes - including sharps bins and advice on safer disposal safer injecting advice when providing long needles

Equipment and advice Needle and syringe programme providers should encourage people who inject drugs to: use syringe identification methods use harm reduction services stop using drugs or to switch to non-injecting methods address their other health needs advise where these services can be accessed

Provide sharps bins, advice on safer disposal Provide a service for safe disposal of used equipment Ensure Hepatitis B vaccination is available for staff Ensure staff can provide signposting and referral to local agencies offering further support Community pharmacy NSP

Staff should be trained for the level of service they offer Staff should receive health and safety training For level 2 or 3 services, staff should be trained to provide health promotion advice Training should also incorporate how to treat controlled drug using clients in a non-stigmatising way Community pharmacy NSP Training

Provide a selection of individual needles, syringes and other injecting equipment Offer harm-reduction services including: - safer injecting and overdose prevention advice - help to stop injecting drugs - and referral to opioid substitution therapy (OST) Offer (or refer to) specialist services including, OST, vaccinations, wound care and welfare and advocacy Specialist NSPs

Discussion How can we engage NSP clients in service planning consultations? What is the profile of our NSP clients? Are we also meeting the needs of people who inject stimulants? How are we dealing with drug-related litter? How can we monitor the training and competencies of staff working for commissioned services?

Find out more Visit for the: guidance quick reference guide Costing statement and costing template audit support local authority planning checklist factsheet for commissioners